Sterling Capital Management’s Roivant Sciences ROIV Stock Holding History

Sterling Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$521K	Buy	14,722 +401	+3%	+$11.8K	0.01%	792
2026 Q1	$397K	Sell	14,321 -8,792	-38%	-$226K	0.01%	881
2025 Q4	$502K	Sell	23,113 -992	-4%	-$19.6K	0.01%	919
2025 Q3	$365K	Sell	24,105 -1,113	-4%	-$13.8K	0.01%	1114
2025 Q2	$284K	Buy	25,218 +1,928	+8%	+$20.9K	﹤0.01%	1180
2025 Q1	$235K	Sell	23,290 -1,922	-8%	-$20.8K	﹤0.01%	1161
2024 Q4	$298K	Buy	25,212 +9,060	+56%	+$107K	﹤0.01%	1168
2024 Q3	$186K	Buy	+16,152	New	+$184K	﹤0.01%	1278

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Sterling Capital Management's ROIV Position: Q2 2026 in Review

Sterling Capital Management increased its Roivant Sciences (ROIV) stake by 2.8% in Q2 2026, buying an estimated $11.8K and bringing the position to 14,722 shares worth $521K. The position accounts for 0.01% of the portfolio, ranked #792.

Sterling Capital Management first reported a position in ROIV in Q3 2024 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Sterling Capital Management held 14,722 shares of Roivant Sciences worth $521K as of Q2 2026.
Sterling Capital Management bought 401 Roivant Sciences shares in Q2 2026, an estimated $11.8K.
Roivant Sciences made up 0.01% of Sterling Capital Management's portfolio in Q2 2026, its #792 holding.
Sterling Capital Management first reported a position in Roivant Sciences in Q3 2024 and has held it in 8 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.